Comparison between the disease-specific Airways Questionnaire 20 and the generic 15D instruments in COPD

Health and Quality of Life Outcomes

Volumn 9, Issue , 2011, Pages

  Mazur, Witold ^a   Kupiainen, Henna ^a   Pitkäniemi, Janne ^b   Kilpeläinen, Maritta ^c   Sintonen, Harri ^b   Lindqvist, Ari ^a   Kinnula, Vuokko L ^a   Laitinen, Tarja ^d  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREATHING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY DISEASE QUESTIONNAIRE; CLINICAL PRACTICE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; COUGHING; DAILY LIFE ACTIVITY; DISEASE SPECIFIC AIRWAYS QUESTIONNAIRE 20; DYSPNEA; EXERCISE; FACTORIAL ANALYSIS; FEMALE; HEALTH SURVEY; HOSPITAL PATIENT; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; REPRODUCIBILITY; SCORING SYSTEM; SEX DIFFERENCE; SEXUAL BEHAVIOR; SLEEP; ST. GEORGE RESPIRATORY QUESTIONNAIRE; SYMPTOM; VALIDITY; VARIMAX ROTATION; WORK; COMPARATIVE STUDY; FINLAND; HEALTH CARE QUALITY; HOSPITALIZATION; LUNG; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; VALIDATION STUDY;

AGED; COHORT STUDIES; FACTOR ANALYSIS, STATISTICAL; FEMALE; FINLAND; HOSPITALIZATION; HUMANS; LUNG; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY INDICATORS, HEALTH CARE; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 78651379346     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-9-4     Document Type: Article

References (43)

1. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007, 370:741-750. 10.1016/S0140-6736(07)61377-4, 17765523.
2. Menezes AM, Perez-Padilla R, Jardim JR, Muino A, Lopez MV, Valdivia G, Montes de Oca M, Talamo C, Hallal PC, Victora CG. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005, 366:1875-1881. 10.1016/S0140-6736(05)67632-5, 16310554.
3. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997, 349:1269-1276. 10.1016/S0140-6736(96)07493-4, 9142060.
4. ATS Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society. Am J Respir Crit Care Med 1999, 159:321-340. ATS.
5. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007, 176:532-555. 10.1164/rccm.200703-456SO, 17507545.
6. Quirk FH, Jones PW. Repeatibility of two new short airways questionnaires. Thorax 1994, 49:1075-1079.
7. Quirk FH, Jones PW. Back to basics: how many items can adequately represent health-related quality of lifein airways disease?. Eur Respir Rev 1997, 7:50-52.
8. Bergner M, Bobbit RA, Carter WB, Golson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981, 18:787-805.
9. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Oga T, Izumi T. A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD. Chest 1999, 116:1632-1637. 10.1378/chest.116.6.1632, 10593787.
10. Hawthorne G, Richardson J, Day NA. A comparison of the Assessment of Quality of Life (AQoL) with four other generic utility instruments. Ann Med 2001, 33:358-370. 10.3109/07853890109002090, 11491195.
11. Hunt SM, McEwen J. The development of a subjective health indicator. Sociol Health Illn 1980, 2:231-246. 10.1111/1467-9566.ep11340686, 10298135.
12. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med 1991, 85(Suppl B):25-31. discussion 33-27., 10.1016/S0954-6111(06)80166-6, 1759018.
13. Kaplan RM, Atkins CJ, Timms R. Validity of a quality of well-being scale as an outcome measure in chronic obstructive pulmonary disease. J Chronic Dis 1984, 37:85-95. 10.1016/0021-9681(84)90050-X, 6420431.
14. Kaplan RM, Feeny D, Revicki DA. Methods for assessing relative importance in preference based outcome measures. Qual Life Res 1993, 2:467-475. 10.1007/BF00422221, 8161981.
15. Mahler DA. How should health-related quality of life be assessed in patients with COPD?. Chest 2000, 117:54S-57S. 10.1378/chest.117.2_suppl.54S, 10673476.
16. Brooks R. EuroQol: the current state of play. Health Policy 1996, 37:53-72. 10.1016/0168-8510(96)00822-6, 10158943.
17. EuroQoL EuroQol--a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990, 16:199-208. 10.1016/0168-8510(90)90421-9, 10109801, EuroQoL.
18. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001, 33:337-343. 10.3109/07853890109002087, 11491192.
19. Rutten-van Molken MP, Oostenbrink JB, Tashkin DP, Burkhart D, Monz BU. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?. Chest 2006, 130:1117-1128. 10.1378/chest.130.4.1117, 17035446.
20. Alemayehu B, Aubert RE, Feifer RA, Paul LD. Comparative analysis of two quality-of-life instruments for patients with chronic obstructive pulmonary disease. Value Health 2002, 5:437-442. 10.1046/j.1524-4733.2002.55151.x, 12201861.
21. Barley EA, Quirk FH, Jones PW. Asthma health status measurement in clinical practice: validity of a new short and simple instrument. Respir Med 1998, 92:1207-1214. 10.1016/S0954-6111(98)90423-1, 9926151.
22. Camelier A, Rosa FW, Jones PW, Jardim JR. Brazilian version of airways questionnaire 20: a reproducibility study and correlations in patients with COPD. Respir Med 2005, 99:602-608. 10.1016/j.rmed.2004.09.022, 15823458.
23. Chen H, Eisner MD, Katz PP, Yelin EH, Blanc PD. Measuring disease-specific quality of life in obstructive airway disease: validation of a modified version of the airways questionnaire 20. Chest 2006, 129:1644-1652. 10.1378/chest.129.6.1644, 16778287.
24. Hajiro T, Nishimura K, Jones PW, Tsukino M, Ikeda A, Koyama H, Izumi T. A novel, short, and simple questionnaire to measure health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 159:1874-1878.
25. Kauppinen R, Rissanen P, Sintonen H. Agreement between a generic and disease-specific quality-of-life instrument: the 15D and the SGRQ in asthmatic patients. Qual Life Res 2000, 9:997-1003. 10.1023/A:1016698818258, 11332228.
26. Saarni SI, Harkanen T, Sintonen H, Suvisaari J, Koskinen S, Aromaa A, Lonnqvist J. The impact of 29 chronic conditions on health-related quality of life: a general population survey in Finland using 15D and EQ-5D. Qual Life Res 2006, 15:1403-1414. 10.1007/s11136-006-0020-1, 16960751.
27. Stavem K. Reliability, validity and responsiveness of two multiattribute utility measures in patients with chronic obstructive pulmonary disease. Qual Life Res 1999, 8:45-54. 10.1023/A:1026475531996, 10457737.
28. Laitinen T, Hodgson U, Kupiainen H, Tammilehto L, Haahtela T, Kilpelainen M, Lindqvist A, Kinnula VL. Real-world clinical data identifies gender-related profiles in chronic obstructive pulmonary disease. Copd 2009, 6:256-262. 10.1080/15412550903051799, 19811384.
29. . GOLD, (Ed.) Global Strategy for Diagnosis, Management and Prevention of COPD. 2008, GOLD, (Ed.)., http://www.goldcopd.com
30. Aromaa A, Koskinen S, . (Eds.) Health and Functional Capacity in Finland. Baseline Results of Health 2000 Health Examination Survey. 2004, Helsinki: National Public Health Institute, (Eds.).
31. Sintonen H. The 15D instrument of health-related quality of life: properties and applications. Ann Med 2001, 33:328-336. 10.3109/07853890109002086, 11491191.
32. Moock J, Kohlmann T. Comparing preference-based quality-of-life measures: results from rehabilitation patients with musculoskeletal, cardiovascular, or psychosomatic disorders. Qual Life Res 2008, 17:485-495. 10.1007/s11136-008-9317-6, 18288590.
33. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987, 42:773-778. 460950, 3321537, 10.1136/thx.42.10.773.
34. Monninkhof E, van der Valk P, Schermer T, van der Palen J, van Herwaarden C, Zielhuis G. Economic evaluation of a comprehensive self-management programme in patients with moderate to severe chronic obstructive pulmonary disease. Chron Respir Dis 2004, 1:7-16.
35. Nishimura K, Oga T, Ikeda A, Hajiro T, Tsukino M, Koyama H. Comparison of health-related quality of life measurements using a single value in patients with asthma and chronic obstructive pulmonary disease. J Asthma 2008, 45:615-620. 10.1080/02770900802127014, 18773337.
36. Puhan MA, Guyatt GH, Goldstein R, Mador J, McKim D, Stahl E, Griffith L, Schunemann HJ. Relative responsiveness of the Chronic Respiratory Questionnaire, St. Georges Respiratory Questionnaire and four other health-related quality of life instruments for patients with chronic lung disease. Respir Med 2007, 101:308-316. 10.1016/j.rmed.2006.04.023, 16782320.
37. Ramsey SD, Sullivan SD, Kaplan RM, Wood DE, Chiang YP, Wagner JL. Economic analysis of lung volume reduction surgery as part of the National Emphysema Treatment Trial. NETT Research Group. Ann Thorac Surg 2001, 71:995-1002. 10.1016/S0003-4975(00)02283-9, 11269488.
38. Szende A, Leidy NK, Stahl E, Svensson K. Estimating health utilities in patients with asthma and COPD: evidence on the performance of EQ-5D and SF-6D. Qual Life Res 2009, 18:267-272. 10.1007/s11136-008-9429-z, 19105049.
39. Stahl E, Lindberg A, Jansson SA, Ronmark E, Svensson K, Andersson F, Lofdahl CG, Lundback B. Health-related quality of life is related to COPD disease severity. Health Qual Life Outcomes 2005, 3:56. 1215504, 16153294, 10.1186/1477-7525-3-56.
40. Guyatt GH, King DR, Feeny DH, Stubbing D, Goldstein RS. Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation. J Clin Epidemiol 1999, 52:187-192. 10.1016/S0895-4356(98)00157-7, 10210235.
41. Ries AL, Kaplan RM, Limberg TM, Prewitt LM. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med 1995, 122:823-832.
42. Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, Hanania NA. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest 2008, 134:43S-56S. 2849676, 18842932, 10.1378/chest.08-0342.
43. Koseoglu N, Koseoglu H, Ceylan E, Cimrin HA, Ozalevli S, Esen A. Erectile dysfunction prevalence and sexual function status in patients with chronic obstructive pulmonary disease. J Urol 2005, 174:249-252. 10.1097/01.ju.0000163259.33846.74, 15947648.